替扎尼定预防治疗慢性每日头痛的研究进展
作者：苟婴茹;杨邦祥;
Author：
收稿日期： 年卷（期）页码：2006,(06):-623-624
期刊名称：华西药学杂志
Journal Name：WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字：盐酸替扎尼定;慢性每日头痛
Key words：
基金项目：
中文摘要
综述了α2肾上腺素能受体激动剂盐酸替扎尼定用于预防治疗慢性每日头痛的临床研究,并讨论了可能的作用机理。
参考文献
[1]W ang SJ,Fuh JL,Lu SR,et al.Chron ic d ialy headache in Ch i-nese elderly:prevalence,risk factors,and b iannual follow-up[J].Neurology,2000,54:314-319.
[2]Lake,A lvin E.Chron ic headache:new advances in treatm entstrategies[J].Neurology,2002,59(5):S8-S13.
[3]S ilberstein SD,Rosenberg J.Mu ltispecialty consensus on d iagno-sis and treatm ent of headache[J].Neurology,2000,54:1553.
[4]王翠兰,郭洪志.慢性每日头痛的诊断与治疗[J].临床神经病学杂志,2004,17(5):389-391.
[5]Nance PW.A lpha-adrenergic and serotinergic agents in thetreatm ent of spastic hyperton ia[J].PhysM ed Rehab C lin NorthAm,2001,12:889-904.
[6]Sh imomura T,Awak i E,Kowa H,et a.l Treatm ent of tensiontype headache w ith tizan id ine hydrochloride:its efficacy and rela-tionsh ip to the plasma MHPG concentration[J].Headache,1991,31:601-604.
[7]Krusz JC,Belanger J,M ills C.Tizan id ine:a novel effective a-gent for the treatm ent of chron ic headaches[J].headache Q,2000,11:41-45.
[8]Saper JR,W inner PK,Lake AE 3 rd.An open-label dose-ti-tration study of the efficacy and tolerab ility of tizan id ine hydro-chloride tab lets in the prophylaxis of chron ic daily headache[J].Headache,2001,41:357-368.
[9]Saper JR,Lake AE 3 rd,Cantrell DT,et a.l Chron ic daily head-ache prophylaxis w ith tizan id ine:a doub le-b lind,placebo-controlled,mu lticenter outcom e study[J].Headache,2002,42:470-482.
[10]Sm ith TR.Low-dose tizan id ine w ith nonsterod ial anti-inflam-matory drugs for detoxification from analgesic rebound headache[J].headache,2002,42:175-177.
[11]Burstein R,CutrerMF,Yarn itsky D.The developm ent of cuta-neous allodyn ia during a m igraine attack:clin ical evidence for thesequential recru itm ent of sp inal and suprasp inal nociceptive neu-rons in m igraine[J].B raiin 2000,123:1703-1709.
[12]Burstein R.D econstructing m igraine headache into peripheraland central sensitization[J].Pain,2001,89:107-110.
[13]W elch KM,Nagesh V,Aurora S,et al.Periaqueductal graymatter dysfunction in m igraine:cause or the burden of illness?[J].Headache,2001,41:629?637.
【关闭】
